Keywords
How to Cite
Abstract
This article discusses the regeneration of cardiomyocytes and highlights recent advances in cardiomyocyte regeneration, focusing on the molecular mechanisms underlying myocardial repair and the translation of these findings into potential therapeutic applications. Particular attention is given to stem cell–based therapies, cellular reprogramming, gene editing technologies, and bioengineering approaches that aim to restore cardiac function following injury.
References
Joshi, J. (2024). Human iPSC-derived cardiomyocytes: Opportunities and challenges in cardiac regeneration. Frontiers in Cell and Developmental Biology.
Wang, L., Zhao, H., & Xu, T. (2023). Advances in cardiac tissue engineering and regenerative medicine. Frontiers in Cardiovascular Medicine.
Shen, Z., Wang, Y., Li, H., & Zhang, L. (2024). In vivo targeted cardiac reprogramming: New approaches to myocardial regeneration. Bioengineering (MDPI).
Barile, L., Vassalli, G., & Moccetti, T. (2021). Extracellular vesicles in myocardial repair: Translational perspectives. Journal of Extracellular Vesicles.
Miura, T. et al. (2022). MicroRNA-based therapies for cardiomyocyte proliferation. Circulation Research.
Ahmad, W., Dutta, S., He, X., Chen, S., Saleem, M. Z., Wang, Y., & Liang, J. (2025). In Vivo Targeted Reprogramming of Cardiac Fibroblasts for Heart Regeneration: Advances and Therapeutic Potential. Bioengineering, 12(9), 940.
Living Nanofiber-Enabled Cardiac Patches for Myocardial Injury (2025). JACC: Basic to Translational Science, 10(2), 227-240.
Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review (2021). Journal of the American College of Cardiology, 78(21), 2092-2105.
This work is licensed under a Creative Commons Attribution 4.0 International License.
